Intraocular Lenses for the Treatment of Age-Related Cataracts
Identifieur interne : 002293 ( Ncbi/Checkpoint ); précédent : 002292; suivant : 002294Intraocular Lenses for the Treatment of Age-Related Cataracts
Auteurs :Source :
- Ontario Health Technology Assessment Series [ 1915-7398 ] ; 2009.
Abstract
The objective of the report is to examine the comparative effectiveness and cost-effectiveness of various intraocular lenses (IOLs) for the treatment of age-related cataracts.
A cataract is a hardening and clouding of the normally transparent crystalline lens that may result in a progressive loss of vision depending on its size, location and density. The condition is typically bilateral, seriously compromises visual acuity and contrast sensitivity and increases glare. Cataracts can also affect people at any age, however, they usually occur as a part of the natural aging process. The occurrence of cataracts increases with age from about 12% at age 50 years, to 60% at age 70. In general, approximately 50% of people 65 year of age or older have cataracts. Mild cataracts can be treated with a change in prescription glasses, while more serious symptoms are treated by surgical removal of the cataract and implantation of an IOL.
In Ontario, the estimated prevalence of cataracts increased from 697,000 in 1992 to 947,000 in 2004 (35.9% increase, 2.4% annual increase). The number of cataract surgeries per 1,000 individuals at risk of cataract increased from 64.6 in 1992 to 140.4 in 1997 (61.9% increase, 10.1% annual increase) and continued to steadily increase to 115.7 in 2004 (10.7% increase, 5.2% increase per year).
IOLs are classified either as monofocal, multifocal, or accommodative. Traditionally, monofocal (i.e.. fixed focusing power) IOLs are available as replacement lenses but their implantation can cause a loss of the eye’s accommodative capability (which allows variable focusing). Patients thus usually require eyeglasses after surgery for reading and near vision tasks. Multifocal IOLs aim to improve near and distant vision and obviate the need for glasses. Potential disadvantages include reduced contrast sensitivity, halos around lights and glare. Accommodating IOLs are designed to move with ciliary body contraction during accommodation and, therefore, offer a continuous range of vision (i.e. near, intermediate and distant vision) without the need for glasses. Purported advantages over multifocal IOLs include the avoidance of haloes and no reduction in contrast sensitivity.
Polymethyl methacrylate (
A literature search was conducted from January 2003 to January 2009 that included OVID MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, the Cumulative Index to Nursing & Allied Health Literature (CINAHL), The Cochrane Library, and the International Agency for Health Technology Assessment/Centre for Review and Dissemination.
Inclusion Criteria | Exclusion Criteria |
---|---|
adult patients with age-related cataracts systematic reviews, randomized controlled trials (RCTs) primary outcomes: distance visual acuity (best corrected distance visual acuity), near visual acuity (best distance corrected near visual acuity) secondary outcomes: contrast sensitivity, depth of field, glare, quality of life, visual function, spectacle dependence, posterior capsule opacification. | studies with fewer than 20 eyes IOLs for non-age related cataracts IOLs for presbyopia studies with a mean follow-up <6months studies reporting insufficient data for analysis |
The primary comparison of interest was accommodative vs. multifocal vs. monofocal lenses.
Secondary comparisons of interest included:
tinted vs. non-tinted lenses
aspheric vs. spheric lenses
multipiece vs. single piece lenses
biomaterial A (e.g. acrylic) vs. biomaterial B (e.g. silicone) lenses
sharp vs. round edged lenses
The quality of the studies was examined according to the GRADE Working Group criteria for grading quality of evidence for interventional procedures.
The conclusions of the systematic review of IOLs for age-related cataracts are summarized in Executive Summary
Procedures for crystalline lens removal and IOL insertion are insured and listed in the Ontario Schedule of Benefits.
If a particular lens is determined to be medically necessary for a patient, the cost of the lens is covered by the hospital budget. If the patient chooses a lens that has enhanced features, then the hospital may choose to charge an additional amount above the cost of the usual lens offered.
An IOL manufacturer stated that monofocal lenses comprise approximately 95% of IOL sales in Ontario and premium lenses (e.g., multifocal/accomodative) consist of about 5% of IOL sales.
A medical consultant stated that all types of lenses are currently being used in Ontario (e.g., multifocal, monofocal, accommodative, tinted, nontinted, spheric, and aspheric). Nonfoldable lenses, rarely used in routine cases, are primarily used for complicated cataract implantation situations.
Comparison | Conclusion | GRADE Quality |
---|---|---|
Multifocal vs. monofocal | ||
Accommodative vs. multifocal/monofocal | Inconclusive due to Insufficient limited evidence for any effectiveness outcome | very low |
Hydrophilic acrylic vs. other materials (hydrophobic acrylic, silicone) | Significant increase in PCO score | Low |
Sharp edged compared to round edged | Significant reduction in PCO score | Low |
One piece compared to three piece | No significant difference in PCO score | low |
Hydrophobic acrylic compared to silicone | No significant difference in PCO score | moderate |
Aspherical modified prolate anterior surface compared to spherical | No significant difference in VA | very low |
Blue light filtering compared to non blue-light filtering | No significant difference in BCDVA | low |
BCDVA refers to best corrected distance visual acuity; BDCUNVA, best distance corrected unaided near visual acuity; HRQL, health related quality of life; PCO, posterior capsule opacification; VA, visual acuity.
Url:
PubMed: 23074519
PubMed Central: 3377510
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001503
- to stream Pmc, to step Curation: 001503
- to stream Pmc, to step Checkpoint: 002126
- to stream Ncbi, to step Merge: 002293
- to stream Ncbi, to step Curation: 002293
Links to Exploration step
PMC:3377510Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intraocular Lenses for the Treatment of Age-Related Cataracts</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23074519</idno>
<idno type="pmc">3377510</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377510</idno>
<idno type="RBID">PMC:3377510</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">001503</idno>
<idno type="wicri:Area/Pmc/Curation">001503</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002126</idno>
<idno type="wicri:Area/Ncbi/Merge">002293</idno>
<idno type="wicri:Area/Ncbi/Curation">002293</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002293</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Intraocular Lenses for the Treatment of Age-Related Cataracts</title>
</analytic>
<series><title level="j">Ontario Health Technology Assessment Series</title>
<idno type="eISSN">1915-7398</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Executive Summary</title>
<sec id="A01lev1sec1"><title>Objective</title>
<p>The objective of the report is to examine the comparative effectiveness and cost-effectiveness of various intraocular lenses (IOLs) for the treatment of age-related cataracts.</p>
</sec>
<sec id="A01lev1sec2"><title>Clinical Need: Target Population and Condition</title>
<p>A cataract is a hardening and clouding of the normally transparent crystalline lens that may result in a progressive loss of vision depending on its size, location and density. The condition is typically bilateral, seriously compromises visual acuity and contrast sensitivity and increases glare. Cataracts can also affect people at any age, however, they usually occur as a part of the natural aging process. The occurrence of cataracts increases with age from about 12% at age 50 years, to 60% at age 70. In general, approximately 50% of people 65 year of age or older have cataracts. Mild cataracts can be treated with a change in prescription glasses, while more serious symptoms are treated by surgical removal of the cataract and implantation of an IOL.</p>
<p>In Ontario, the estimated prevalence of cataracts increased from 697,000 in 1992 to 947,000 in 2004 (35.9% increase, 2.4% annual increase). The number of cataract surgeries per 1,000 individuals at risk of cataract increased from 64.6 in 1992 to 140.4 in 1997 (61.9% increase, 10.1% annual increase) and continued to steadily increase to 115.7 in 2004 (10.7% increase, 5.2% increase per year).</p>
</sec>
<sec id="A01lev1sec3"><title>Description of Technology/Therapy</title>
<p>IOLs are classified either as monofocal, multifocal, or accommodative. Traditionally, monofocal (i.e.. fixed focusing power) IOLs are available as replacement lenses but their implantation can cause a loss of the eye’s accommodative capability (which allows variable focusing). Patients thus usually require eyeglasses after surgery for reading and near vision tasks. Multifocal IOLs aim to improve near and distant vision and obviate the need for glasses. Potential disadvantages include reduced contrast sensitivity, halos around lights and glare. Accommodating IOLs are designed to move with ciliary body contraction during accommodation and, therefore, offer a continuous range of vision (i.e. near, intermediate and distant vision) without the need for glasses. Purported advantages over multifocal IOLs include the avoidance of haloes and no reduction in contrast sensitivity.</p>
<p>Polymethyl methacrylate (<abbrev>PMMA</abbrev>
) was the first material used in the fabrication of IOLs and has inherent ultraviolet blocking abilities. PMMA IOLs are inflexible, however, and require a larger incision for implantation compared with newer foldable silicone (hydrophobic) and acrylic (hydrophobic or hydrophilic) lenses. IOLs can be further sub-classified as being either aspheric or spheric, blue/violet filtered or non-filtered or 1- or 3-piece.</p>
</sec>
<sec id="A01lev1sec4"><title>Methods of Evidence-Based Analysis</title>
<p>A literature search was conducted from January 2003 to January 2009 that included OVID MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, the Cumulative Index to Nursing & Allied Health Literature (CINAHL), The Cochrane Library, and the International Agency for Health Technology Assessment/Centre for Review and Dissemination.</p>
<table-wrap id="A01table01" orientation="portrait" position="anchor"><table frame="void" rules="none" cellspacing="2" cellpadding="2" border="1"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Inclusion Criteria</th>
<th valign="top" align="left" rowspan="1" colspan="1">Exclusion Criteria</th>
</tr>
</thead>
<tbody><tr><td valign="top" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>adult patients with age-related cataracts</p>
</list-item>
<list-item><p>systematic reviews, randomized controlled trials (RCTs)</p>
</list-item>
<list-item><p>primary outcomes: distance visual acuity (best corrected distance visual acuity), near visual acuity (best distance corrected near visual acuity)</p>
</list-item>
<list-item><p>secondary outcomes: contrast sensitivity, depth of field, glare, quality of life, visual function, spectacle dependence, posterior capsule opacification.</p>
</list-item>
</list>
</td>
<td valign="top" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>studies with fewer than 20 eyes</p>
</list-item>
<list-item><p>IOLs for non-age related cataracts</p>
</list-item>
<list-item><p>IOLs for presbyopia</p>
</list-item>
<list-item><p>studies with a mean follow-up <6months</p>
</list-item>
<list-item><p>studies reporting insufficient data for analysis</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="A01lev2sec1"><title>Comparisons of Interest</title>
<p>The primary comparison of interest was accommodative vs. multifocal vs. monofocal lenses.</p>
<p>Secondary comparisons of interest included:</p>
<list list-type="bullet"><list-item><p>tinted vs. non-tinted lenses</p>
</list-item>
<list-item><p>aspheric vs. spheric lenses</p>
</list-item>
<list-item><p>multipiece vs. single piece lenses</p>
</list-item>
<list-item><p>biomaterial A (e.g. acrylic) vs. biomaterial B (e.g. silicone) lenses</p>
</list-item>
<list-item><p>sharp vs. round edged lenses</p>
</list-item>
</list>
<p>The quality of the studies was examined according to the GRADE Working Group criteria for grading quality of evidence for interventional procedures.</p>
</sec>
</sec>
<sec id="A01lev1sec5"><title>Summary of Findings</title>
<p>The conclusions of the systematic review of IOLs for age-related cataracts are summarized in Executive Summary <xref rid="A01tab01" ref-type="table">Table 1</xref>
.</p>
</sec>
<sec id="A01lev1sec6"><title>Considerations for the Ontario Health System</title>
<list list-type="bullet"><list-item><p>Procedures for crystalline lens removal and IOL insertion are insured and listed in the Ontario Schedule of Benefits.</p>
</list-item>
<list-item><p>If a particular lens is determined to be medically necessary for a patient, the cost of the lens is covered by the hospital budget. If the patient chooses a lens that has enhanced features, then the hospital may choose to charge an additional amount above the cost of the usual lens offered.</p>
</list-item>
<list-item><p>An IOL manufacturer stated that monofocal lenses comprise approximately 95% of IOL sales in Ontario and premium lenses (e.g., multifocal/accomodative) consist of about 5% of IOL sales.</p>
</list-item>
<list-item><p>A medical consultant stated that all types of lenses are currently being used in Ontario (e.g., multifocal, monofocal, accommodative, tinted, nontinted, spheric, and aspheric). Nonfoldable lenses, rarely used in routine cases, are primarily used for complicated cataract implantation situations.</p>
</list-item>
</list>
<table-wrap id="A01estab01" orientation="portrait" position="float"><label>ES Table 1:</label>
<caption><title>Conclusions for the Systematic Review of IOLs for Age-Related Cataracts</title>
</caption>
<table frame="hsides" rules="rows" cellspacing="2" cellpadding="2" border="1"><thead><tr><th style="background-color: #C0C0C0" valign="bottom" align="left" rowspan="1" colspan="1">Comparison</th>
<th style="background-color: #C0C0C0" valign="bottom" align="left" rowspan="1" colspan="1">Conclusion</th>
<th style="background-color: #C0C0C0" valign="bottom" align="left" rowspan="1" colspan="1">GRADE Quality</th>
</tr>
</thead>
<tbody><tr><td valign="top" rowspan="1" colspan="1">Multifocal vs. monofocal</td>
<td valign="top" rowspan="1" colspan="1"><underline>Objective Outcomes</underline>
<break></break>
Significant improvement in BDCUNVA<break></break>
No significant difference in BCDVA<break></break>
Inconclusive evidence for contrast sensitivity<break></break>
Inconclusive evidence for glare<break></break>
<break></break>
<underline>Subjective Outcomes</underline>
<break></break>
Inconclusive evidence for visual satisfaction<break></break>
Significant increase in glare/halos<break></break>
Significant increase in freedom from spectacles</td>
<td valign="top" rowspan="1" colspan="1"><break></break>
moderate<break></break>
moderate<break></break>
low<break></break>
very low<break></break>
<break></break>
<break></break>
low<break></break>
low/moderate<break></break>
low/moderate</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Accommodative vs. multifocal/monofocal</td>
<td valign="top" rowspan="1" colspan="1">Inconclusive due to Insufficient limited evidence for any effectiveness outcome</td>
<td valign="top" rowspan="1" colspan="1">very low</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Hydrophilic acrylic vs. other materials (hydrophobic acrylic, silicone)</td>
<td valign="top" rowspan="1" colspan="1">Significant increase in PCO score</td>
<td valign="top" rowspan="1" colspan="1">Low</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Sharp edged compared to round edged</td>
<td valign="top" rowspan="1" colspan="1">Significant reduction in PCO score</td>
<td valign="top" rowspan="1" colspan="1">Low</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">One piece compared to three piece</td>
<td valign="top" rowspan="1" colspan="1">No significant difference in PCO score</td>
<td valign="top" rowspan="1" colspan="1">low</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Hydrophobic acrylic compared to silicone</td>
<td valign="top" rowspan="1" colspan="1">No significant difference in PCO score</td>
<td valign="top" rowspan="1" colspan="1">moderate</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Aspherical modified prolate anterior surface compared to spherical</td>
<td valign="top" rowspan="1" colspan="1">No significant difference in VA<break></break>
Significant reduction in contrast sensitivity</td>
<td valign="top" rowspan="1" colspan="1">very low<break></break>
very low</td>
</tr>
<tr><td valign="top" rowspan="1" colspan="1">Blue light filtering compared to non blue-light filtering</td>
<td valign="top" rowspan="1" colspan="1">No significant difference in BCDVA<break></break>
No significant difference in contrast sensitivity<break></break>
No significant difference in HRQL</td>
<td valign="top" rowspan="1" colspan="1">low<break></break>
low<break></break>
high/moderate</td>
</tr>
</tbody>
</table>
<table-wrap-foot><fn><label></label>
<p>BCDVA refers to best corrected distance visual acuity; BDCUNVA, best distance corrected unaided near visual acuity; HRQL, health related quality of life; PCO, posterior capsule opacification; VA, visual acuity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002293 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 002293 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= HapticV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= PMC:3377510 |texte= Intraocular Lenses for the Treatment of Age-Related Cataracts }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:23074519" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a HapticV1
This area was generated with Dilib version V0.6.23. |